header logo image


Page 1,160«..1020..1,1591,1601,1611,162..1,1701,180..»

What Is A Stem Cell, Stem Cell Questions, How Do Stem …

July 8th, 2015 6:42 pm

Our Technology

Phoenix Stem Cell Treatment Center uses adipose derived stem cells for deployment & clinical research. Early stem cell research has traditionally been associated with the controversial use of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are found in a persons own blood, bone marrow, and fat. Most stem cell treatment centers in the world are currently using stem cells derived from bone marrow.

A recent technological breakthrough enables us to now use adipose (fat) derived stem cells. Autologous stem cells from a persons own fat are easy to harvest safely under local anesthesia and are abundant in quantities up to 2500 times those seen in bone marrow.

Clinical success and favorable outcomes appear to be related directly to the quantity of stem cells deployed. Once these adipose derived stem cells are administered back in to the patient, they have the potential to repair human tissue by forming new cells of mesenchymal origin, such as cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells ability to form cartilage and bone makes them potentially highly effective in the treatment of degenerative orthopedic conditions. Their ability to form new blood vessels and smooth muscle makes them potentially very useful in the treatment of peyronies disease and impotence. Stem cells are used extensively in Europe and Asia to treat these conditions.

We have anecdotal and experimental evidence that stem cell therapy is effective in healing and regeneration. Stem cells seek out damaged tissues in order to repair the body naturally. The literature and internet is full of successful testimonials but we are still awaiting definitive studies demonstrating efficacy of stem cell therapy. Such data may take five or ten years to accumulate. At the Phoenix Stem Cell Treatment Center we are committed to gathering those data by conducting sound and effective clinical research. In an effort to provide relief for patients suffering from certain degenerative diseases that have been resistant to common modalities of treatment, we are initiating pilot studies as experimental tests of treatment effectiveness with very high numbers of adipose derived stem cells obtained from fat. Adipose fat is an abundant and reliable source of stem cells.

Phoenix Stem Cell Treatment Centers cell harvesting and isolation techniques are based on technology from Korea. This new technological breakthrough allows patients to safely receive their own autologous stem cells in extremely large quantities. Our treatments and research are patient funded and we have endeavored successfully to make it affordable. All of our sterile procedures are non-invasive and done under local anesthesia. Patients who are looking for non-surgical alternatives to their degenerative disorders can participate in our trials by filling out our treatment application to determine if they are candidates. Phoenix Stem Cell Treatment Center is proud to be state of the art in the new field of Regenerative Medicine.RETURN TO TOP

We are currently in the process of setting up FDA approved protocols for stem cell banking in collaboration with a reputable cryo-technology company. This enables a person to receive autologous stem cells at any time in the future without having to undergo liposuction which may be inconvenient or contraindicated. Having your own stem cells available for medical immediate use is a valuable medical asset.

Provisions are nearly in place for this option and storage of your own stem cells obtained by liposuction at PSCTC or from fat obtained from cosmetic procedures performed elsewhere should be possible in the near future.RETURN TO TOP

Adult (NonEmbryonic) Mesenchymal Stem Cells are undifferentiated cells that have the ability to replace dying cells and regenerate damaged tissue. These special cells seek out areas of injury, disease and destruction where they are capable of regenerating healthy cells and enabling a persons natural healing processes to be accelerated. As we gain a deeper understanding of their medical function and apply this knowledge, we are realizing their enormous therapeutic potential to help the body heal itself. Adult stem cells have been used for a variety of medical treatments to repair and regenerate acute and chronicially damaged tissues in humans and animals. The use of stem cells is not FDA approved for the treatment of any specific disease in the United States at this time and their use is therefore investigational. Many reputable international centers have been using stem cell therapy to treat various chronic degenerative conditions as diverse as severe neurologic diseases, renal failure, erectile dysfunction, degenerative orthopedic problems, and even cardiac and pulmonary diseases to name a few. Adult stem cells appear to be particularly effective at repairing cartilage in degenerated joints.RETURN TO TOP

Regenerative Medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to damage, or congenital defects. This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable organs to heal themselves. (Wikipedia)RETURN TO TOP

See more here:
What Is A Stem Cell, Stem Cell Questions, How Do Stem ...

Read More...

Preventive Medicine – Miami Children’s Hospital

July 7th, 2015 8:45 pm

Division of Community Pediatrics and Preventive Medicine

Mission and Vision

Mission: To provide early, accessible preventive and interventional health services to improve the health status of children and adolescents in South Florida by early identification of risk factors that affect their health through the implementation of clinical, educational and research programs.

Vision: Nicklaus Children's Hospital, formerly Miami Children's Hospital, will be recognized as a national leader in disease prevention, health policy/advocacy and health promotion efforts by addressing the health needs of children and adolescents. This vision will be driven by ongoing monitoring, assessment leading to policy-making oriented towards the prevention of diseases and related risk factors, therefore improving morbidity and mortality rates

School-Based Programs

The Nicklaus Children's Hospital, formerly Miami Children's Hospital, Division of Community Pediatrics and Preventive Medicine is partnering with The Childrens Trust of Miami-Dade County to offer school-based health clinics, as part of the Health Connect in Our Schools Program.

This initiative, which provides a nurse practitioner and licensed practical nurse (LPN) at high-risk schools, provides preventive and basic school health services in an effort to decrease absenteeism and improve health outcomes of the student population. The program also seeks to assign medical homes for children without a pediatrician.

For more information on this program, please call 305-663-6800.

See the original post here:
Preventive Medicine - Miami Children's Hospital

Read More...

Genetic Medicine : Division Home | Department of Medicine

July 7th, 2015 8:43 pm

Advances in molecular biology and human genetics, coupled with the completion of the Human Genome Project and the increasing power of quantitative genetics to identify disease susceptibility genes, are contributing to a revolution in the practice of medicine. In the 21st century, practicing physicians will focus more on defining genetically determined disease susceptibility in individual patients. This strategy will be used to prevent, modify, and treat a wide array of common disorders that have unique heritable risk factors such as hypertension, obesity, diabetes, arthrosclerosis, and cancer.

The Division of Genetic Medicine provides an academic environment enabling researchers to explore new relationships between disease susceptibility and human genetics. The Division of Genetic Medicine was established to host both research and clinical research programs focused on the genetic basis of health and disease. Equipped with state-of-the-art research tools and facilities, our faculty members are advancing knowledge of the common genetic determinants of cancer, congenital neuropathies, and heart disease. The Division faculty work jointly with the Vanderbilt-Ingram Cancer Center to support the Hereditary Cancer Clinic for treating patients and families who have an inherited predisposition to various malignancies.

View post:
Genetic Medicine : Division Home | Department of Medicine

Read More...

Functional Endocrinology Of Ohio – Natural Alternative …

July 6th, 2015 11:43 am

Welcome to Functional Endocrinology of Ohio

To give Hope to those who lost it, Healing to those who need it,and Inspiration to those who seek it to restore people to their God-given health potential is what we do.

For more information or to schedule an appointment in either our Akron or Independence office, click on the blue button above orcall (330) 644-5488 (Akron)or (216) 236-0060(Independence) today! Also, be sure to read about and sign up forour Exclusive Offer below and subscribe to one of our email/video newsletters by clicking on the Newsletter buttonabove. We also offer free workshops and classes. Click on the calendar tab above to check out the schedule and then call or email us to register. You can also view the full 2013 class schedule by clicking here.

Functional Endocrinology of Ohio is a functional, naturalmedicine and chiropractic practice devoted to maintaining the lifetime health and wellness of our clients from a metabolic, neurologic, and structural standpoint. Whether you are suffering from a particular health condition (like diabetes, thyroid, autoimmune, fibromyalgia, MTHFR, etc.) or fromback pain, neck pain, knee pain, neuropathy, headaches, or even just plain old muscular tightness and tension, we can help - naturally!See our full list of conditions treated by clicking on the "Conditions Treated" tab above.

When you come to our office,Functional Endocrinology of Ohio,we will explain the science behind how functional medicine, in conjunction with chiropractic care (in some cases), works to help you with all of your health issues. We will then conduct a full exam and case history to see if our treatment protocols are right for you.If there is a good fit, we willdevelop a treatment plan that is CUSTOMIZED toYOUR condition and health goals.

Ifyou want to find out more, please email us or call (330) 644-5488 or (216) 236-0060 to learn more fromour friendly team. We also welcome referrals, so feel free to use the "Send to a Friend" link located at the bottom of every page to share our health information with your friends and loved ones.

If you would like to stay informed about cutting edge health and wellness issues and treatments,or if you want to start receiving free articles about health and wellness news, please subscribe to ournewsletter, even if you are not a client. Once you are subscribed, you will be receive articles,videos and other resources directly in your email in-box so that you can learn more.

Dr. Keith S. Ungar,Dr. David Starkey, Dr. Andrew Kender

Akron and Cleveland Chiropractic Physicians

Originally posted here:
Functional Endocrinology Of Ohio - Natural Alternative ...

Read More...

Genetic determinants of exceptional human longevity …

July 6th, 2015 9:45 am

Age (Dordr). 2006 Dec; 28(4): 313332.

1College of Nursing, Okinawa Prefectural University, 1-24-1 Yogi, Naha City, Okinawa Japan 902-0076

2Pacific Health Research Institute, 846 South Hotel Street, Suite 301, Honolulu, HI 96813 USA

3Departments of Geriatric Medicine and Medicine, John A. Burns School of Medicine, University of Hawaii, 1356 Lusitana Street, 7F, Honolulu, HI 96813 USA

4School of Medicine, University of California San Francisco, 74 New Montgomery Street, Suite 600, San Francisco, CA 94105 USA

52200 Post Street, C433, San Francisco, CA 94143-1640 USA

6Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, Japan

Received 2006 Jun 6; Revised 2006 Sep 30; Accepted 2006 Oct 1.

Centenarians represent a rare phenotype appearing in roughly 1020 per 100,000 persons in most industrialized countries but as high as 4050 per 100,000 persons in Okinawa, Japan. Siblings of centenarians in Okinawa have been found to have cumulative survival advantages such that female centenarian siblings have a 2.58-fold likelihood and male siblings a 5.43-fold likelihood (versus their birth cohorts) of reaching the age of 90years. This is indicative of a strong familial component to longevity. Centenarians may live such extraordinarily long lives in large part due to genetic variations that either affect the rate of aging and/or have genes that result in decreased susceptibility to age-associated diseases. Some of the most promising candidate genes appear to be those involved in regulatory pathways such as insulin signaling, immunoinflammatory response, stress resistance or cardiovascular function. Although gene variants with large beneficial effects have been suggested to exist, only APOE, an important regulator of lipoproteins has been consistently associated with a longer human lifespan across numerous populations. As longevity is a very complex trait, several issues challenge our ability to identify its genetic influences, such as control for environmental confounders across time, the lack of precise phenotypes of aging and longevity, statistical power, study design and availability of appropriate study populations. Genetic studies on the Okinawan population suggest that Okinawans are a genetically distinct group that has several characteristics of a founder population, including less genetic diversity, and clustering of specific gene variants, some of which may be related to longevity. Further work on this population and other genetic isolates would be of significant interest to the genetics of human longevity.

Key words: longevity, genetics, centenarians, Okinawa, longevity genes

Read the original:
Genetic determinants of exceptional human longevity ...

Read More...

Overview | Institute for Aging Research | Albert Einstein …

July 6th, 2015 9:45 am

The Institute for Aging Research conducts focused multidisciplinary investigations to unravel essential elements in the biology of aging.

The New York Times and NPR feature Nir Barzilai, M.D., and one of his centenarian study participants in a joint article on aging. (November 19, 2014)

The New York Times profiles Nir Barzilai, M.D. (September 27, 2014)

Wall Street Journal features new research by Nir Barzilai, M.D. that found lower levels of growth hormone are associated with extended lifespan in centenarians. (March 25, 2014)

The Scientist features Ana Maria Cuervo's discovery of how cells selectively break down their waste, and the health consequences that arise when that process malfunctions. (November 1, 2013)

Scientific American interviews Nir Barzilai, M.D., about latest research advances for slowing or delaying the aging process in humans. Dr. Barzilai, who conducts longevity research with centenarians, notes his superagers tend to have a significant delay in the onset of age-related diseases and stay healthier longer. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

Nature features Nir Barzilai, M.D., and his proposed TAME study, which will investigate if the widely used diabetes drug metformin can delay aging. Dr. Barzilai notes that he and his colleagues are not seeking the fountain of youth, but rather an effective means to extend the number of healthy years an individual has, or healthspan. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

The Scientist interviews Nir Barzilai, M.D., and Evris Gavathiotis, Ph.D., about their success in pursuing private funding in the face of federal funding cuts. Drs. Barzilai and Gavathiotis share how they identified and pursued alternative funding sources and how it has helped advance their research. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center. Dr. Gavathiotis is assistant professor of biochemistry and of medicine.

The New York Timesreferences Einsteins centenarian studies and Nir Barzilai, M.D., in an obituary on 109-year old Irving Kahn. Kahn, considered the oldest active Wall Street investor before his death, was a participant in Dr. Barzilais studies at EinsteinsInstitute of Aging Research. He was also profiled as part of EinsteinsLongevity Genes Project video series. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center.

Visit link:
Overview | Institute for Aging Research | Albert Einstein ...

Read More...

Genetic Improvement of Dairy Cow Longevity – eXtension

July 6th, 2015 9:45 am

Annual herd turnover rates and reported reasons for culling may be misleading, and the timing of culling during the lactation can be a more useful indicator of potential management problems on a given farm. Conformation traits are often used to select for improved cow longevity, but these traits account for only a modest proportion of differences in cow survival. Significant genetic variation exists between sires in the length of productive life of their daughters, as well as susceptibility to specific health disorders. Genetic improvement of cow survival should focus on direct measures of longevity, fertility, and health.

Dairy cow survival is influenced by many factors. Non-genetic factors include stall size, bedding type, degree of overcrowding, heat abatement devices, nutrition, veterinary care, herd expansion plans, milk quota restrictions, and availability and affordability of replacement heifers. As shown below, genetic improvement of longevity involves breeding animals that can produce a live calf without assistance; cycle normally, show visible heat, and conceive when inseminated; maintain adequate body condition and resist metabolic disorders; avoid udder injuries and fight off infection by mastitis pathogens; walk and stand comfortably without frequent hoof trimming, and efficiently produce milk of desirable composition. Many cows fail to complete these tasks and leave the herd prematurely. In some cases, the cow is genetically flawed, while in other cases her environment is lacking. Significant genetic variation exists between sire families for longevity, fertility, calving performance, and disease resistance. Therefore, we can improve longevity directly by selecting families that resist culling, or we can improve longevity indirectly by selecting families that excel for each of its component traits.

Please check this link first if you are interested in organic or specialty dairy production

Much negative attention has been given to the annual turnover or replacement rates on commercial dairy farms. However, the overall replacement rate for a given herd doesnt provide enough information to indicate whether or not a problem exists; one needs to know which cows left the herd, as well as the reasons for and timing of their removal. Suppose that 35% of the milking cows in each of two dairies were replaced last year. In one herd, the majority of these were low-producing, older animals that were culled late in lactation and subsequently replaced by younger, genetically superior heifers grown from within the operation. In the other herd, the majority were young, high-producing cows that were culled or died early in lactation due to calving problems, mastitis, lameness, ketosis, and other metabolic disorders, and the owner was forced to buy springing heifers from a cattle dealer at the prevailing market price. Thus, even though the replacement rates on these farms are identical, ones interpretation of each herd's management success is vastly different. Replacement rates can also be misleading in herds that have an excess of replacement heifers. Suppose one herd sells its extra animals as springing heifers prior to first calving, while another herd calves all of its heifers and culls stringently for low production within the milking herd. Both may be successful in terms of managing the health, fertility, and productivity of their cattle, but the former will have a substantially lower annual replacement rate. In general, herds with lower replacement or turnover rates tend to be more successful in terms of cow comfort, health, and productivity. However, replacement rates can be misleading, and more detailed information about the reasons for culling and the timing of culling is needed. Furthermore, herd turnover rates are influenced heavily by external factors, such as expansion plans and replacement heifer prices.

Dairy producers routinely report reasons for disposal as part of the national milk recording program. Animals can be recorded as died, sold for dairy, or sold for beef, with the latter category broken down into low production, mastitis, infertility, and so on. These descriptive reasons for disposal can be useful when studying the general demographics of a national dairy herd. For example, one might use such data to conclude that mastitis and infertility are the most common causes of culling on most dairy farms. However, reported reasons for disposal can be misleading when one attempts to compare the management level of various dairy farms, or when one attempts to draw conclusions about the genetic merit of certain animals or sire families. Many animals are culled for multiple offenses. For example, a cow might have a difficult calving, followed by a case of ketosis, and a displaced abomasum. She may then fail to breed back in a timely manner and be culled from the herd when her daily milk production drops below a profitable level. The farmer might code her as sold for low production, sold for infertility, or sold due to disease. Thus, the reported reason for disposal is often a vague indicator of the actual problem. Furthermore, inconsistencies may exist between reported reasons for disposal and the actual health and reproductive history of the culled animals.

Stewart (Steve Stewart, Univ. of Minnesota, 2002, unpublished) proposed the idea of using the timing of culling within the lactation as an indirect indicator of the reason for disposal. He constructed a graph showing the proportion of total culled animals that were removed within certain time periods during the lactation. An example of this type of graph is shown below, where the percentage of culled cows that left during each 3-week period from calving to 440 d postpartum is shown for 59,390 cows that calved in 2001-2003 and were subsequently culled from 151 herds that participate in the Alta Genetics (Watertown, WI) Advantage Progeny Testing Program. One can hypothesize that cows that were culled between 0 and 62 d postpartum may have left due to calving problems or early lactation metabolic disorders, while cows that were culled between 63 and 293 d postpartum may have left due to mastitis or lameness, and cows that were culled after 294 d postpartum may have left due to infertility. Exceptions to the rule exist, as a cow that is culled today may actually reflect the outcome of a do not breed decision that occurred many months earlier. Nonetheless, an analysis of the timing of culling events within a dairy herd may provide a more objective description of management on a given farm than one can obtain by inspecting the overall turnover rate or reported reasons for disposal. Furthermore, genetic evaluation of dairy sires based on the proportion of daughters that were culled during each period of the lactation may provide a useful indicator of differences in susceptibility to various diseases or disorders. For example, one could compute sire predicted transmitting abilities for early lactation survival, and this might identify bulls whose daughters avoid calving complications and resist early postpartum metabolic disorders.

Initial attempts to improve dairy cow longevity through artificial selection began in the 1970s and early 1980s when breed associations and AI studs first developed linear type appraisal programs. For the next two decades, type and longevity were considered as synonymous. Bulls that sired daughters with high, wide rear udders, strong median suspensory ligaments, well-attached fore udders, and correct teat placement were considered to transmit superior longevity. Likewise, bulls that sired daughters with strong pasterns, a steep foot angle, and correct set to the hock were expected to improve longevity.

Numerous studies have addressed the genetic relationships between linear type traits and longevity (e.g., Caraviello et al., 2004a; Sewalem et al, 2004; Short and Lawlor, 1992). Early studies relied on the estimation of genetic correlations between longevity and linear type traits, and these studies typically invoked a 60-, 72-, or 84-month opportunity period for longevity. However, these studies suffered from two major limitations. First, the use of genetic correlation parameters to assess trait-longevity relationships limited these studies to measurement of linear relationships only. Few traits have a strictly linear relationship with longevity, and the role of traits with intermediate optima or traits that offer diminishing returns as scores increase cannot be evaluated properly using genetic correlations. Second, the use of a long opportunity period, to allow each cow to fully express her genetic potential for longevity, resulted in a tremendous time lag between the birth of animals in the study group and eventual publication of results. For example, the youngest cows in the Short and Lawlor (1992) study were born in 1982, so more than a decade of additional genetic and management improvements occurred prior to publication of results of the study. The use of survival analysis methodology in more recent studies (e.g., Caraviello et al., 2004b) alleviated several of the aforementioned limitations. In many of these studies, linear type scores were grouped into categories, and no restrictions were placed on the form of the trait-longevity relationship. Furthermore, because survival analysis allows proper modeling of censored records from animals that are still alive (Ducrocq, 1994), these studies used much more timely data than previous studies that invoked a long opportunity period. Results indicated that many type traits, such as rear leg set, rump angle, or dairy form, have intermediate optima, while many others, such as udder support, teat placement, or foot angle, seem to display a pattern of diminishing returns. More importantly, these studies demonstrated that udder depth, fore udder attachment, rear udder attachment, and udder support were of primary importance with respect to longevity, while rear leg set and foot angle were of secondary importance, and stature had no importance. Despite the importance of physical conformation, a significant proportion of the genetic variation in longevity remained unexplained by existing type or production traits well into the 1990s. Numerous examples were noted of bulls that transmitted outstanding production and type to their daughters but whose daughters nonetheless tended to leave the herd prematurely. Thus, type traits can be used as an indirect indicator of the expected longevity of a bull's daughters, and actual culling and fertility data are needed to explain the rest of the story.

In 1994, the USDA Animal Improvement Programs Laboratory (Beltsville, MD) introduced national genetic evaluations for length of productive life (PL), which was measured as the total number of months in milk from first calving until 84 mo of age, with a limit of 10 mo per lactation (VanRaden and Klaaskate, 1993). Because the vast majority of cows are culled by 84 mo of age, this seems to provide a reasonable opportunity period. In fact, the additional gain in accuracy that could be achieved by waiting for a few, highly selected daughters to complete 8, 10, or 12 yr of PL would be negligible. Because the starting point of the opportunity period (date of first calving) can vary, it is possible that this definition of PL may favor animals that calve at a young age. However, the phenotypic variation in age at first calving on most commercial dairies is rather limited. The limit of 10 mo of PL per lactation was applied for two reasons: because it seemed desirable to penalize cows that have a long dry period and an extended calving interval and because test-day production data beyond 305 d postpartum were unavailable historically. However, this restriction may have some unintended consequences, in terms of the genetic relationships between PL and other traits in the breeding goal. Tsuruta et al. (2005) showed that the genetic correlation between milk yield and PL changed from -0.11 with a 305 d limit, to +0.08 with a 500 d limit, and to +0.14 with a 999 d limit. Corresponding genetic correlations between days open and PL were -0.62, -0.36, and -0.27 for per lactation PL limits of 305 d, 500 d, and 999 d, respectively, while genetic correlations with dairy form were -0.25, -0.12, and -0.08, respectively. An extension of the current 305 d limit to a value that is more closely aligned with the management of modern commercial dairies, such as 365 d or 400 d, has been discussed. An additional argument for extending, or even removing, a limit on PL credits per lactation is that national dairy sire evaluations for daughter pregnancy rate (DPR) are now routinely available, and indirect selection for fertility using PL information is no longer necessary. An important aspect of current national genetic evaluations for PL is that records of cows that are still alive can be extended or projected to obtain an estimate of the total months in milk that such animals will accumulate by culling or 84 mo of age (VanRaden and Klaaskate, 1993). Thus, the 84-mo opportunity period does not cause a major delay or time lag in computing sire PTA for PL. On the other hand, the accuracy of such projections is low much lower than the accuracy of projected 305 d milk production records based on the first two or three test-day yields.

The primary concern with regard to genetic evaluation of PL is the substantial period of time required to obtain complete culling data for daughters of a given bull. Because a short generation interval is desirable in genetic selection programs, AI studs and pedigree breeders like to make sire selection decisions as quickly as possible. However, when a recently tested sire is being considered as a sire of sons or as an embryo transfer sire, most of his daughters are still alive. Therefore, reliability of PL evaluations is often low at the most critical points in life. This can lead to errors in selection decisions, particularly for bulls whose daughters fail to follow a typical maturity pattern. If a particular bull's daughters mature more or less gracefully than daughters of an average bull, his PTA can change significantly over time. Weigel et al. (1998) developed a procedure by which correlated traits, such as type, production, and somatic cell score, can be used to compute an indirect prediction of a bulls PTA for PL. The indirect prediction for a given bull can then be combined with his direct prediction, which is based on actual culling data, using weights that depend on the REL of direct and indirect predictions. The combined PTA will have higher REL than either the direct or indirect prediction, especially early in life. Although the combined PL predictions tend to be more accurate than direct predictions for the majority of sires, there are exceptions. The most disturbing cases are bulls whose daughters appear promising in first lactation but mature less gracefully than daughters of an average bull. These bulls tend to have a high indirect prediction early in life, but their combined PTA tends to decrease over time, as daughters mature and get culled from the herd more rapidly than anticipated.

Here is the original post:
Genetic Improvement of Dairy Cow Longevity - eXtension

Read More...

Steamed Longevity Peach-shaped Buns | Marishia’s …

July 6th, 2015 9:44 am

The Longevity Bun is similar to pau/bao but with a unique shape of a peach. The bun is airbrushed with a reddish/pinkish colorful top. You can make them in single bun or double (join 2 buns together to get a 3D image of a peach. It is stuffed with red bean paste or lotus paste or custard. It is available in the marketplace or Chinese pastry bakery or restaurants (for special occasionslike birthday or birth) too but not that popular.

Also the longevity buns are used for ritual events (Birthdays of Goddess, God or Saints) to offer their prayers. These Longevity buns are made to symbolize those immortality and magical peaches. It also symbolizes a collective aspiration and reflects traditional values that respect the elderly.

It is a challenge for me because I try many times but could not get the right shape and texture. After a few attempts, I managed to come out with this recipe and turn out well in time for the Chinese New Year celebration and be able to share with you all. What a long journey for me on working this piece of work.

Makes 20-22 buns

Ingredients:

Dough:

2 cups All Purpose flour

Read more:
Steamed Longevity Peach-shaped Buns | Marishia's ...

Read More...

Life Extension Information, Research and Products

July 6th, 2015 9:44 am

Summary: If you want to live longer and stay healthy your chances are better if you substantially reduce or eliminate sugar-sweetened beverages from your diet.

Consumption of sugary drinks may lead to an estimated 184,000 adult deaths each year worldwide, according to research published today in the journal Circulation and previously presented as an abstract at the American Heart Association Council on Epidemiology and Prevention in 2013.

Many countries in the world have a significant number of deaths occurring from a single dietary factor, sugar-sweetened beverages. It should be a global priority to substantially reduce or eliminate sugar-sweetened beverages from the diet, said Dariush Mozaffarian, M.D., Dr.P.H., senior author of the study and dean of the Friedman School of Nutrition Science & Policy at Tufts University in Boston.

In the first detailed global report on the impact of sugar-sweetened beverages, researchers estimated deaths and disabilities from diabetes, heart disease, and cancers in 2010. In this analysis, sugar sweetened beverages were defined as any sugar-sweetened sodas, fruit drinks, sports/energy drinks, sweetened iced teas, or homemade sugary drinks such as frescas, that contained at least 50 kcal per 8oz serving. 100 percent fruit juice was excluded.

Estimates of consumption were made from 62 dietary surveys including 611,971 individuals conducted between 1980 and 2010 across 51 countries, along with data on national availability of sugar in 187 countries and other information. This allowed capture of geographical, gender and age variation in consumption levels of sugar-sweetened beverages in different populations. Based on meta-analyses of other published evidence on health harms of sugar-sweetened beverages, the investigators calculated the direct impact on diabetes and the obesity-related effects on cardiovascular disease, diabetes and cancer.

In 2010, the researchers estimate that sugar-sweetened beverages consumption may have been responsible for approximately:

133,000 deaths from diabetes

45,000 deaths from cardiovascular disease

6,450 deaths from cancer

Some population dietary changes, such as increasing fruits and vegetables, can be challenging due to agriculture, costs, storage, and other complexities. This is not complicated. There are no health benefits from sugar-sweetened beverages, and the potential impact of reducing consumption is saving tens of thousands of deaths each year, Mozaffarian said.

Link:
Life Extension Information, Research and Products

Read More...

Medical Genetics at University of Washington

July 6th, 2015 9:43 am

Medical Genetics Faculty, Fellows & Staff: 2014

The University of Washington Department of Medicine is recruiting for one (1) full-time faculty position at the Associate Professor, or Professor level in the Division of Medical Genetics, Department of Medicine. This position is offered with state tenure funding.

Successful candidates for this position will have an M.D./Ph.D. or M.D. degree (or foreign equivalent), clinical expertise in genetics, and will be expected to carry out a successful research program. Highly translational PhD (or foreign equivalent) scientists may be considered. Although candidates with productive research programs in translational genetics/genomics and/or precision medicine will be prioritized, investigators engaged in gene therapy research may also be considered.

The position will remain open until filled. Send CV and 1-2 page letter of interest to:

Medical Genetics Faculty Search c/o Sara Carlson Division of Medical Genetics University of Washington seisner@u.washington.edu

The rest is here:
Medical Genetics at University of Washington

Read More...

Genetic engineering: a guide for kids by Tiki the Penguin

July 6th, 2015 9:43 am

Genetic engineering (GE for short) is about scientists altering the 'recipes' for making life the genes which you find in all living things. Doing this is very clever and seems to be very useful. Back in the 1990s, many 'Greens' campaigned against genetic engineering and still do. They predicted disaster but that hasn't happened. Nobody has died from eating genetically modified (GM) food. They were also worried about the private GE companies' ownership of the recipes genes for making these new life forms. So is genetic engineering okay? My guide explains the basics but it's up to you to make up your own mind about GE.

Finding your way around my GE Guide You can jump to any part that interests you from the table below. If you want to start at the beginning, click the green arrow below (forward to 'Genes, snails and whales').

Table of contents

Genes, snails and whales What makes you human or me a penguin? What are genes?

Tried and tested Life on Earth has been around for a long time so it's been well tested.

Adapt or die Only the fittest life survives. Here's how it does it.

Coils and corkscrews About that incredible stuff DNA.

Copycat: How DNA copies itself.

Read the original:
Genetic engineering: a guide for kids by Tiki the Penguin

Read More...

Surprising Secrets to Longevity

July 5th, 2015 11:49 am

By Dr. Mercola

Many have studied the reasons for longevity. Why do some people live longer than others? Is it genetics? Is it culture, or perhaps lifestyle?

James Smith, a health economist at the RAND Corporation, delved into the prevailing mystery of why some groups of people live longer than others. What he found you might find surprising. I certainly did. The number one social factor that correlated with long life was not geographic region or health or socioeconomic status, but education.

Among the most important things you can do to help lengthen your children's lives is to keep them in school, according to Dr. Smith. And he's not the only one who has come to this conclusion, as you will discover in this New York Times article.1

The National Institute on Aging finds education is the most important social factor for longevity in study after study, dominating other factors such as income, race and health insurance. Columbia University graduate student Adriana Lleras-Muney found that your life expectancy at age 35 is extended by one and a half years simply by going to school for one extra year.

These findings imply that sinking our precious national dollars into health insurance programs will never give us as much "bang for our buck" as directing those funds toward education.

Dr. Smith suggests education may teach people how to delay gratification and think ahead. Education may teach you how to plan for your future, as opposed to simply living for the moment. Besides education, what other social factors may extend your life?

Harvard Professor of Public Policy Lisa Berkman cites social isolation as a significant factor in longevity. If you're socially isolated, you may experience poor health and a shorter lifespan. This may be, at least in part, because those who don't have good social networks may not be able to get assistance if they become ill.

Is there a health-wealth connection? Yes, there is, according to Dr. Smith. An analysis of Medicare beneficiaries performed by Dartmouth College found the lowest death rates are seen in the wealthiest places.

Current studies suggest getting rich does not make you healthier, but getting sick does make you poorer. Low income doesn't lead to poor health as much as poor health leads to low income, according to the latest research. This is largely due to the fact that, if you develop cancer, heart disease, diabetes or another serious disease, your medical expenses rise while your ability to work declines. For countries like England and Sweden that have universal health insurance, there is no difference in longevity between the rich and the poor.

Here is the original post:
Surprising Secrets to Longevity

Read More...

Health Benefits of Chocolate – Longevity Advice from About.com

July 5th, 2015 11:49 am

Chris Turner/Stone/Getty Images

Updated December 19, 2014.

Why is Dark Chocolate Healthy?:

Chocolate is made from plants, which means it contains many of the health benefits of dark vegetables as part of your anti-aging diet. These benefits are from flavonoids, which act as antioxidants. Antioxidants protect the body from aging caused by free radicals, which can cause damage that leads to heart disease. Dark chocolate contains a large number of antioxidants (nearly 8 times the number found in strawberries).

Flavonoids also help relax blood pressure through the production of nitric oxide, and balance certain hormones in the body.

In fact, cocoa and chocolate products have been used as medicine in many cultures for centuries.

Heart Health Benefits of Dark Chocolate:

Dark chocolate is good for your heart. A small bar of it everyday can help keep your heart and cardiovascular system running well. Two heart health benefits of dark chocolate are:

Other Benefits of Dark Chocolate:

Chocolate also holds benefits apart from protecting your heart:

Original post:
Health Benefits of Chocolate - Longevity Advice from About.com

Read More...

Cholesterol, longevity, intelligence, and health.

July 5th, 2015 11:49 am

A R T I C L E

Cholesterol, longevity, intelligence, and health. The biological meaning of cholesterol is just starting to be explored. Everything that doctors know about cholesterol is wrong. New information about cholesterol is clarifying important issues in physiology and pathology. Medical magazines and television stations like to propagate the idea that cholesterol is bad stuff, and as a result, that cliche is known to almost every American. Recent journal articles have promoted the idea that "the lower the serum cholesterol is, the better" it is for the health of the patient.

The theory that heart disease is "caused by cholesterol" has gone through several stages, and most recently the use of the "statin" drugs has revived it in a radical way. One consistent theme for fifty years has been that people should eat more polyunsaturated fat and less saturated fat, to lower their cholesterol, and to avoid butter, cream, eggs, and "red meat," because they contain both saturated fat and cholesterol. Often, medical attention is focused on the fats in the atheroma, rather than on the whole disease process, including clotting factors, vascular spasms, heart rhythm, viscosity of the blood, deposition of calcium and iron in blood vessels, and the whole process of inflammation, including the reactions to absorbed bowel toxins.

Almost 100 years ago, some experiments in Russia showed that feeding rabbits cholesterol caused them to develop atherosclerosis, but subsequent experiments showed that rabbits are unusual in responding that way to cholesterol, and that even rabbits don't develop atherosclerosis from cholesterol if they are given a supplement of thyroid (Friedland, 1933). By 1936, it was clear that hypercholesterolemia in humans and other animals was caused by hypothyroidism, and that hypothyroidism caused many diseases to develop, including cardiovascular disease and cancer. There was already more reason at that time to think that the increased cholesterol was a protective adaptation than to think that it was maladaptive.

The strange idea that cholesterol causes atherosclerosis was revived in the 1950s when the vegetable oil industry learned that their polyunsaturated oils lowered serum cholesterol. (Many other toxins lower cholesterol, but that is never mentioned.) The industry began advertising their oils as "heart protective," and they enlisted some influential organizations to help in their advertising: The American Dietetic Association, the American Heart Association, the US Dept. of Agriculture and FDA, and the AMA. Besides the early rabbit research, which didn't make their case against cholesterol and might actually have had implications harmful to their argument (since Anitschkow had used vegetable oil as solvent for his cholesterol feedings), the oil industry helped to create and promote a large amount of fraudulent and unscientific work.

The death rate from heart disease in the United States began increasing early in the twentieth century, and it reached its peak from about 1950 to 1975, and then began declining. During the decades in which the death rate was rising, consumption of animal fat was decreasing, and the use of vegetable oil was increasing. In the southern European countries that have been said to show that eating very little animal fat prevents heart disease, the trends after the second world war have been the opposite--they have been eating more animal fat without an increase in heart disease.

The correspondence between heart disease and consumption of saturated fat and cholesterol is little more than advertising copy. If people were looking for the actual causes of heart disease, they would consider the factors that changed in the US during the time that heart disease mortality was increasing. Both increases in harmful factors, and decreases in protective factors would have to be considered.

The consumption of manufactured foods, pollution of air and water, the use of lead in gasoline, cigarette smoking, increased medicalization and use of drugs, psychosocial and socioeconomic stress, and increased exposure to radiation--medical, military, and industrial--would be obvious things to consider, along with decreased intake of some protective nutrients, such as selenium, magnesium, and vitamins.

But those harmful factors all had their defenders: Who defends socioeconomic stress? All of the social institutions that fail to alleviate it. In 1847, Rudolph Virchow was sent to Poland to study the health situation there, and when he returned, the highly regarded anatomist, physiologist and pathologist announced that the Poles wouldn't have a health problem if the government would stop oppressing them, and institute economic reforms to alleviate their poverty. The reforms weren't made, and Virchow lost his job. Other harmful factors, such as seed oils, degraded foods, and radiation, have specific, very well organized and powerful lobbies to defend them.

Despite the growing knowledge about the dangers of polyunsaturated fats, many medical articles are still advocating the "official" heart protective diet (e.g., "... diets using nonhydrogenated unsaturated fats as the predominant form of dietary fat," Hu and Willet, 2002).

Read the original post:
Cholesterol, longevity, intelligence, and health.

Read More...

Immune System: MedlinePlus – National Library of Medicine

July 5th, 2015 11:48 am

To use the sharing features on this page, please enable JavaScript. Acquired Immunodeficiency Syndrome see HIV/AIDS Acute Lymphoblastic Leukemia see Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia Addison Disease Adenoidectomy see Tonsils and Adenoids Adenoids see Tonsils and Adenoids Adenovirus Infections see Viral Infections Adrenal Insufficiency see Addison Disease Adult Immunization see Immunization AIDS see HIV/AIDS AIDS and Infections see HIV/AIDS and Infections AIDS and Pregnancy see HIV/AIDS and Pregnancy AIDS in Women see HIV/AIDS in Women AIDS Medicines see HIV/AIDS Medicines AIDS--Living With AIDS see Living with HIV/AIDS ALL see Acute Lymphocytic Leukemia Allergic Rhinitis see Allergy; Hay Fever Allergy Allergy, Food see Food Allergy Allergy, Latex see Latex Allergy Anaphylaxis see Allergy Anatomy Animal Bites Ankylosing Spondylitis Antimicrobial Resistance see Infectious Diseases Aplastic Anemia Asthma Asthma in Children Autoimmune Diseases Autoinflammatory Disorders see Autoimmune Diseases Bone Marrow Diseases Bone Marrow Transplantation Bronchial Asthma see Asthma Bullous Pemphigoid see Pemphigus Cat Bites see Animal Bites Chikungunya see Viral Infections Childhood Asthma see Asthma in Children Childhood Immunization Childhood Leukemia Chronic Granulomatous Disease see Immune System and Disorders Chronic Lymphocytic Leukemia Churg-Strauss Syndrome see Eosinophilic Disorders CLL see Chronic Lymphocytic Leukemia Communicable Diseases see Infectious Diseases Coxsackievirus Infections see Viral Infections Cryptosporidiosis Diabetes Type 1 Dog Bites see Animal Bites Dry Eye see Sjogren's Syndrome EBV Infections see Infectious Mononucleosis Enterovirus see Viral Infections Eosinophilia see Eosinophilic Disorders Eosinophilic Disorders Epstein-Barr Virus Infections see Infectious Mononucleosis Fanconi Anemia see Aplastic Anemia Food Allergy Giant Cell Arteritis Glandular Fever see Infectious Mononucleosis Hand, Foot, and Mouth Disease see Viral Infections Hay Fever HIV/AIDS HIV/AIDS and Infections HIV/AIDS and Pregnancy HIV/AIDS in Women HIV/AIDS Medicines HIV/AIDS--Living With see Living with HIV/AIDS Hives Hodgkin Disease Human Immunodeficiency Virus see HIV/AIDS Hypereosinophilic Syndrome see Eosinophilic Disorders Hypersensitivity see Allergy Immune System and Disorders Immunization Immunization, Childhood see Childhood Immunization Infections, Viral see Viral Infections Infectious Diseases Infectious Mononucleosis Insulin-Dependent Diabetes Mellitus see Diabetes Type 1 JRA see Juvenile Rheumatoid Arthritis Juvenile Diabetes see Diabetes Type 1 Juvenile Rheumatoid Arthritis Kawasaki Disease Latex Allergy Leukemia, Acute Lymphoblastic see Acute Lymphocytic Leukemia Leukemia, Acute Lymphocytic see Acute Lymphocytic Leukemia Leukemia, Childhood see Childhood Leukemia Leukemia, Chronic Lymphocytic see Chronic Lymphocytic Leukemia Living with HIV/AIDS Lupus Lymph Nodes see Lymphatic Diseases Lymphatic Diseases Lymphatic Obstruction see Lymphedema Lymphedema Lymphoma MDS see Myelodysplastic Syndromes Milk Allergy see Food Allergy Mono see Infectious Mononucleosis Mononucleosis see Infectious Mononucleosis Morphea see Scleroderma Mucocutaneous Lymph Node Syndrome see Kawasaki Disease Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Disorders see Bone Marrow Diseases Non-Hodgkin Lymphoma see Lymphoma Nut Allergy see Food Allergy Opportunistic Infections in AIDS see HIV/AIDS and Infections Peanut Allergy see Food Allergy Pemphigoid see Pemphigus Pemphigus Plasma-cell Myeloma see Multiple Myeloma Plasmacytoma see Multiple Myeloma Pneumocystis Infections Pollen Allergy see Hay Fever Pregnancy and AIDS see HIV/AIDS and Pregnancy PrEP (Pre-Exposure Prophylaxis) see HIV/AIDS Medicines Rheumatoid Arthritis Rheumatoid Spondylitis see Ankylosing Spondylitis Roseola see Viral Infections SCID see Immune System and Disorders Scleroderma Seasonal Allergies see Hay Fever Severe Combined Immunodeficiency see Immune System and Disorders Sjogren's Syndrome SLE see Lupus Snake Bites see Animal Bites Spleen Diseases Splenic Diseaess see Spleen Diseases Splenomegaly see Spleen Diseases Spondylitis, Ankylosing see Ankylosing Spondylitis Still's Disease see Juvenile Rheumatoid Arthritis Swollen Glands see Lymphatic Diseases Systemic Lupus Erythematosus see Lupus Systemic Sclerosis see Scleroderma Temporal Arteritis see Giant Cell Arteritis Thymus Cancer Tonsillectomy see Tonsils and Adenoids Tonsillitis see Tonsils and Adenoids Tonsils and Adenoids Type I Diabetes see Diabetes Type 1 Urticaria see Hives Vaccination see Childhood Immunization; Immunization Viral Infections Waldenstrom's Macroglobulinemia see Lymphoma

Originally posted here:
Immune System: MedlinePlus - National Library of Medicine

Read More...

Lack of Sleep and the Immune System – WebMD

July 5th, 2015 11:48 am

Lack of sleep affects your immune system.

Mother knows best -- at least it appears that way when it comes to lack of sleep. It turns out that lack of sleep really may make us more prone to catching colds and the flu. And that includes the H1N1 virus.

It is an old wives tale that if you dont sleep well, you will get sick, and there is some experimental data that shows this is true, says Diwakar Balachandran, MD, director of the Sleep Center at the University of Texas M.D. Anderson Cancer Center in Houston.

When Nightmares Won't Go Away

Yael Levy recalls having chronic nightmares as far back as elementary school, when she was living in Israel. The grandchild of Holocaust survivors, she says her dreams were filled with images of suffering and death. In one recurrent nightmare, Levy was trapped in a concentration camp, facing death. In another, she was drowning in deep water. At their worst, the nightmares occurred on an almost weekly basis, leaving her jittery and desperately fatigued. "I would wake up so terrified that I was afraid...

Read the When Nightmares Won't Go Away article > >

Some 50 million to 70 million American adults suffer from sleep disorders or the inability to stay awake and alert, according to the CDC. Though its not always easy to do, getting adequate sleep can help keep our immune systems primed for attack.

Not getting enough sleep has been linked to a laundry list of mental and physical health problems, including those that stem from an impaired immune system. Our immune system is designed to protect us from colds, flu, and other ailments, but when it is not functioning properly, it fails to do its job. The consequences can include more sick days.

The relationship between lack of sleep and our immune systems is not quite as straightforward as mom made it out to be, however. The immune system is pretty complex. It is made up of several types of cells and proteins that are charged with keeping foreign invaders such as colds or flu at bay.

A lot of studies show our T-cells go down if we are sleep deprived, Balachandran says. And inflammatory cytokines go up. ... This could potentially lead to the greater risk of developing a cold or flu.

Read more:
Lack of Sleep and the Immune System - WebMD

Read More...

Prosopagnosia – Wikipedia, the free encyclopedia

July 5th, 2015 11:46 am

Prosopagnosia (Greek: "prosopon" = "face", "agnosia" = "not knowing"), also called face blindness,[1] is a cognitive disorder of face perception where the ability to recognize faces is impaired, while other aspects of visual processing (e.g., object discrimination) and intellectual functioning (e.g., decision making) remain intact. The term originally referred to a condition following acute brain damage (acquired prosopagnosia), but a congenital or developmental form of the disorder also exists, which may affect up to 2.5% of the population.[2] The specific brain area usually associated with prosopagnosia is the fusiform gyrus,[3] which activates specifically in response to faces. The functionality of the fusiform gyrus allows most people to recognize faces in more detail than they do similarly complex inanimate objects. For those with prosopagnosia, the new method for recognizing faces depends on the less-sensitive object recognition system. The right hemisphere fusiform gyrus is more often involved in familiar face recognition than the left. It remains unclear whether the fusiform gyrus is only specific for the recognition of human faces or if it is also involved in highly trained visual stimuli.

There are two types of prosopagnosia: acquired and congenital (developmental). Acquired prosopagnosia results from occipito-temporal lobe damage and is most often found in adults. This is further subdivided into apperceptive and associative prosopagnosia. In congenital prosopagnosia, the individual never adequately develops the ability to recognize faces.[4]

Though there have been several attempts at remediation, no therapies have demonstrated lasting real-world improvements across a group of prosopagnosics. Prosopagnosics often learn to use "piecemeal" or "feature-by-feature" recognition strategies. This may involve secondary clues such as clothing, gait, hair color, body shape, and voice. Because the face seems to function as an important identifying feature in memory, it can also be difficult for people with this condition to keep track of information about people, and socialize normally with others. Prosopagnosia has also been associated with other disorders that are associated with nearby brain areas: left hemianopsia (loss of vision from left side of space, associated with damage to the right occipital lobe), achromatopsia (a deficit in color perception often associated with unilateral or bilateral lesions in the temporo-occipital junction) and topographical disorientation (a loss of environmental familiarity and difficulties in using landmarks, associated with lesions in the posterior part of the parahippocampal gyrus and anterior part of the lingual gyrus of the right hemisphere).[5]

Apperceptive prosopagnosia has typically been used to describe cases of acquired prosopagnosia with some of the earliest processes in the face perception system. The brain areas thought to play a critical role in apperceptive prosopagnosia are right occipital temporal regions.[6] People with this disorder cannot make any sense of faces and are unable to make same-different judgments when they are presented with pictures of different faces. They are unable to recognize both familiar and unfamiliar faces. However, they may be able to recognize people based on non-face clues such as their clothing, hairstyle or voice.[7]

Associative prosopagnosia has typically been used to describe cases of acquired prosopagnosia with spared perceptual processes but impaired links between early face perception processes and the semantic information we hold about people in our memories. Right anterior temporal regions may also play a critical role in associative prosopagnosia.[6] People with this form of the disorder may be able to say whether photos of people's faces are the same or different and derive the age and sex from a face (suggesting they can make sense of some face information) but may not be able to subsequently identify the person or provide any information about them such as their name, occupation, or when they were last encountered.[6]

Developmental prosopagnosia (DP), also called Congenital prosopagnosia (CP), is a face-recognition deficit that is lifelong, manifesting in early childhood, and that cannot be attributed to acquired brain damage. A number of studies have found functional deficits in DP both on the basis of EEG measures and fMRI. It has been suggested that a genetic factor is responsible for the condition. The term hereditary prosopagnosia was introduced if DP affected more than one family member, essentially accenting the possible genetic contribution of this condition. To examine this possible genetic factor, 689 randomly selected students were administered a survey in which seventeen developmental prosopagnosics were quantifiably identified. Family members of fourteen of the DP individuals were interviewed to determine prosopagnosia-like characteristics, and in all fourteen families, at least one other affected family member was found.[8]

In 2005, a study led by Ingo Kennerknecht showed support for the proposed congenital disorder form of prosopagnosia. This study provides epidemiological evidence that congenital prosopagnosia is a frequently occurring cognitive disorder that often runs in families. The analysis of pedigree trees formed within the study also indicates that the segregation pattern of hereditary prosopagnosia (HPA) is fully compatible with autosomal dominant inheritance. This mode of inheritance explains why HPA is so common among certain families (Kennerknecht et al. 2006).[9]

There are many developmental disorders associated with an increased likelihood that the person will have difficulties in face perception, of which the person may or may not be aware. The mechanism by which these perceptual deficits take place is largely unknown. A partial list of some disorders that often have prosopagnosiac components would include nonverbal learning disorder, Alzheimer's Disease, and autism spectrum disorders in general. However, these types of disorders are very complicated, so arbitrary assumptions should be avoided.[10]

Prosopagnosia can be caused by lesions in various parts of the inferior occipital areas (occipital face area), fusiform gyrus (fusiform face area), and the anterior temporal cortex.[6] Positron emission topography (PET) and fMRI scans have shown that, in individuals without prosopagnosia, these areas are activated specifically in response to face stimuli.[5] The inferior occipital areas are mainly involved in the early stages of face perception and the anterior temporal structures integrate specific information about the face, voice, and name of a familiar person.[6]

Acquired prosopagnosia can develop as the result of several neurologically damaging causes. Vascular causes of prosopagnosia include posterior cerebral artery infarcts (PCAIs) and hemorrhages in the infero-medial part of the temporo-occipital area. These can be either bilateral or unilateral, but if they are unilateral, they are almost always in the right hemisphere.[5] Recent studies have confirmed that right hemisphere damage to the specific temporo-occipital areas mentioned above is sufficient to induce prosopagnosia. MRI scans of patients with prosopagnosia showed lesions isolated to the right hemisphere, while fMRI scans showed that the left hemisphere was functioning normally.[5] Unilateral left temporo-occipital lesions result in object agnosia, but spare face recognition processes, although a few cases have been documented where left unilateral damage resulted in prosopagnosia. It has been suggested that these face recognition impairments caused by left hemisphere damage are due to a semantic defect blocking retrieval processes that are involved in obtaining person-specific semantic information from the visual modality.[6]

Continued here:
Prosopagnosia - Wikipedia, the free encyclopedia

Read More...

Top 10 biotech companies and Top 100 biotechnology places …

July 5th, 2015 11:46 am

Top 10 biotech companies in India 1. Biocon Established in the year 1978 Biocon, global biopharmaceutical enterprise is actively involved in the manufacturing and development of innovative technologies that includes large-scale chemical synthesis, microbial fermentation, mammalian cell culture, purification of protein & antibody and various aseptic formulations. Chairman Kiran Mazumdar-Shaw; Corporate Office Bangalore, India | Sector Private | Website http://www.biocon.com 2. Serum Institute of India Serum Institute of India Ltd. established in the year 1966 is the world's largest producer of Measles and DTP group of vaccines. The company manufactures life-saving Biologicals including Anti-Snake Venom and Tetanus Antitoxin serum, DTP (Diphtheria, Tetanus and Pertussis) and MMR (Measles, Mumps and Rubella) group of vaccines at affordable prices. Chairman Cyrus S. Poonawalla; Location: Pune, India | Sector Private | Website http://www.seruminstitute.com 3. Panacea Biotech Ltd Panacea Biotec established in the year 1976, has strong R and D capabilities with a wide range of pipeline including: Development various complex pharmaceutical generic compounds Technologies) Development of New Chemical Entities (NCE) Vaccines Chairman Soshil Kumar, Corporate Office New Delhi, India | | Business Pharmaceutical, Biotechnology | Sector Private | Website http://www.panacea-biotec.com 4. Novo Nordisk Established in the year 1923, Novo Nordisk is the worlds leader in diabetes care, manufacturing broadest diabetes product that includes development of the most advanced products related to insulin delivery systems. Chairman Sten Scheibye, Corporate Office Denmark, Business -Sector Pharmaceutical- Private | Website http://www.novonordisk.co.in 5. GlaxoSmithKline Pharmaceuticals Ltd. One of the earliest pharmaceutical companies in India is GSK India. It was established in the year 1924. The GSK India is an important group of manufacturing products of wide range of prescription medicines and vaccines in therapeutic areas such as dermatology, anti-infectives, diabetes, oncology, cardiovascular and respiratory diseases. The company also manufactures vaccines for prevention of hepatitis A and B, invasive diseases caused by H. influenzae, chickenpox, DPT, cervical cancer, rotavirus, Streptococcal pneumonia etc. Chairman Chris Gent; Corporate Office London, United Kingdom Business Biotechnology and Pharmaceutical, Sector Private | Website http://www.gsk-india.com 6. SIRO Clinpharm Established in the year 1996 the company provides a wide range of services including Clinical Operations & Clinical Monitoring, Clinical Data management, medical and scientific writing, biostatistics and statistical programming, clinical trial supplies management, pharmacovigilance. Chairman Dr. Gautam Daftary; Corporate Office Thane, India | | | Business Drug Development; Sector Private | Website http://www.siroclinpharm.com 7. Novozymes, South Asia Novozymes a biotech company established in 1925 strongly focus on production of novel enzymes. The companys biosolution provides everything from the removal of trans fats in food to advancements in bioenergy sources. Chairman Kbenhavns Lufthavne; Corporate Office Bagsvaerd, Denmark; Novozymes South Asia Pvt. Ltd. Bangalore, India; Sector Private | Website http://www.novozymes.com 8. Zydus Cadila Zydus Cadila, established in the year 1952, is a fully integrated, global healthcare company with complete healthcare solutions ranging from active pharmaceutical ingredients, formulations products related to animal health care to wellness products. The company is the only Indian pharma establishment that launched the worlds first drug NCE Lipaglyn for treatment of diabetic dyslipidemia. Chairman - Mr. Pankaj R. Patel, Corporate office-Ahmedabad, Sector- Private Website- http://www.zyduscadila.com 9. Indian Immunologicals Indian Immunologicals Ltd. (IIL) was established in 1982 by The National Dairy Development Board (NDDB) with the focus to manufacture Foot and Mouth Disease (FMD) vaccine available to poor people at an affordable price. IIL provides a range of adult as well as child vaccines. Chairman Dr. Amrita Patel; Corporate Office Hyderabad, India Business-sector Biotechnology-private; Website http://www.indimmune.com 10. Wockhardt Ltd. Established in the year 1960 Wockhardt Ltd. is an international manufacturer of biopharmaceutical formulations along with Active Pharmaceutical Ingredients (API). An integrated multi-technology capability was developed by the company for manufacturing all types of dosage formulation that includes sterile injectables and lyophilised products. Chairman Habil Khorakiwala; Corporate Office Mumbai, India; Business Sector Biotechnology and Pharmaceutics-private Website http://www.wockhardt.com

Visit link:
Top 10 biotech companies and Top 100 biotechnology places ...

Read More...

Stem Cell Therapy & Stem Cell Treatment – Cell Therapy …

July 5th, 2015 11:46 am

Our Cell Therapy Center offers advanced patented methods of stem cell treatment for different diseases and conditions. The fetal stem cells we use are pluripotent non-specialized cells able to differentiate (turn) into other cell types. Fetal stem cells have the highest potential for differentiation and proliferation and are not rejected by the recipients body more...

Stem cell therapy has proven to be effective for tissue restoration, and integrated care for the incurable and obstinate diseases. We treat patients with various diseases, such as diabetes mellitus, multiple sclerosis, Parkinsons disease, Duchenne muscular dystrophy, joint and autoimmune diseases, etc. We also offer innovative anti-aging programs. Stem cell treatment allows for achieving effects that are far beyond the capacity of any other modern method more...

For over 21 years, we have performed more than 8,500 transplantations of fetal stem cells to people from many countries, such as the USA, China, Italy, Germany, Denmark, Great Britain, Saudi Arabia, UAE, Egypt, etc. Our stem cell treatments helped to prolong life and improve life quality to thousands of patients including those suffering from the incurable diseases who lost any hope for recovery.

With Cell Therapy Center EmCell located in Kiev, Ukraine, we have numerous partners in various countries devoted to provide medical advice on EmCell stem cell treatment locally.

We are always open for medical, businessandscientificcooperation.

Here is the original post:
Stem Cell Therapy & Stem Cell Treatment - Cell Therapy ...

Read More...

IBMs nanomedicine initiative – IBM Research: Overview

July 4th, 2015 1:44 pm

Creating a hydrogel from the polymers

Through the precise tailoring of the ninja polymers, researchers were able to create macromolecules - molecular structures containing a large number of atoms - which combine water solubility, a positive charge, and biodegradability. When mixed with water and heated to normal body temperature, the polymers self-assemble, swelling into a synthetic hydrogel that is easy to manipulate.

When applied to contaminated surfaces, the hydrogel's positive charge attracts negatively charged microbial membranes, like stars and planets being pulled into a black hole. However, unlike other antimicrobials that target the internal machinery of bacteria to try to prevent it from replicating, this hydrogel destroys the bacteria by rupturing the bacteria's membrane, rendering it completely unable to regenerate or spread.

The hydrogel is comprised of more than 90 percent water, making it easy to handle and apply to surfaces. It also makes it potentially viable for eventual inclusion in applications like creams or injectable therapeutics for wound healing, implant and catheter coatings, skin infections or even orifice barriers. It is the first-ever to be biodegradable, biocompatible and non-toxic, potentially making it an ideal tool to combat serious health hazards facing hospital workers, visitors and patients.

The IBM scientists in the nanomedicine polymer program along with the Institute of Bioengineering and Nanotechnology have taken this research a step further and have made a nanomedicine breakthrough in which they converted common plastic materials like polyethylene terephthalate (PET) into non-toxic and biocompatible materials designed to specifically target and attack fungal infections.BCC Research reported that the treatment cost for fungal infections was $3 billion worldwide in 2010 andis expected to increase to $6 billion in 2014. In this breakthrough, the researchers identified a novel self-assembly process for broken down PET, the primary material in plastic water bottles, in which 'super' molecules are formed through a hydrogen bond and serve as drug carriers targeting fungal infections in the body. Demonstrating characteristics like electrostatic charge similar to polymers, the molecules are able to break through bacterial membranes and eradicate fungus, then biodegrade in the body naturally. This is important to treat eye infections associated with contact lenses, and bloodstream infections like Candida.

See more here:
IBMs nanomedicine initiative - IBM Research: Overview

Read More...

Page 1,160«..1020..1,1591,1601,1611,162..1,1701,180..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick